Kromek Group plc

LSE KMK.L

Kromek Group plc EBITDA for the year ending April 30, 2024: USD 3.66 M

Kromek Group plc EBITDA is USD 3.66 M for the year ending April 30, 2024, a 332.32% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • Kromek Group plc EBITDA for the year ending April 30, 2023 was USD -1.57 M, a -2.09% change year over year.
  • Kromek Group plc EBITDA for the year ending April 30, 2022 was USD -1.54 M, a 35.82% change year over year.
  • Kromek Group plc EBITDA for the year ending April 30, 2021 was USD -2.40 M, a 86.76% change year over year.
  • Kromek Group plc EBITDA for the year ending April 30, 2020 was USD -18.15 M, a -820.06% change year over year.
Key data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)
Market news
Loading...
SV Wall Street
LSE: KMK.L

Kromek Group plc

CEO Dr. Arnab Basu MBE
IPO Date Oct. 16, 2013
Location United Kingdom
Headquarters NETPark
Employees 165
Sector Materials
Industries
Description

Kromek Group plc, together with its subsidiaries, develops, manufactures, and sells radiation detection components and devices for the medical imaging, civil nuclear industry, CBRNe security, and safety screening markets in the United Kingdom, North America, Asia, Europe, Australasia, and Africa. The company's products provide high-resolution information on material composition and structure that are used in various applications, ranging from the identification of cancerous tissues to hazardous materials, such as explosives, as well as the analysis of radioactive materials. It also offers civil nuclear radiation detection products, which include gamma radiation and neutron detectors, high-specification, high-resolution devices, components, and software for nuclear detection problems, as well as offers a range of radiation detectors that use cadmium zinc telluride (CZT) or scintillator technology for gamma-ray, x-ray, and neutron detection. In addition, the company provides medical imaging products, including CZT gamma detectors for SPECT imaging, CZT bone mineral densitometry detectors, and photon-counting spectral CT systems. Further, it offers CBRNE homeland security products and solutions for government, border control, airport and seaports, HazMat teams, ambulance crews, police, and armed forces, as well as a range of gamma spectroscopy software that enables specialized gamma-ray spectroscopy for the analysis of samples. Additionally, the company provides CZT imaging development platforms, such as the DMatrix and the EV3500 scalable x-ray CZT linear array for laboratory and research imaging; and engages in the scientific research and development activities. It sells its products through distributors, OEMs, and direct sales. The company was incorporated in 2013 and is headquartered in Sedgefield, the United Kingdom.

Similar companies

RFX.L

Ramsdens Holdings PLC

USD 2.86

0.02%

StockViz Staff

January 30, 2025

Any question? Send us an email